NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Annals of oncology
Year: 2019, Jahrgang: 30, Pages: iv80 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdz155.290 |
| Online-Zugang: | Verlag, lizenzpflichtig: https://doi.org/10.1093/annonc/mdz155.290 Verlag, lizenzpflichtig: http://www.sciencedirect.com/science/article/pii/S0923753419308075 
|
| Verfasserangaben: | B. Weinberg, D. Renouf, H. Lim, C. Heining, R. Schlenk, M. Jones, S. Liu, A. Cseh, F. Solca, J. Laskin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1695562437 | ||
| 003 | DE-627 | ||
| 005 | 20220818050415.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200421s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdz155.290 |2 doi | |
| 035 | |a (DE-627)1695562437 | ||
| 035 | |a (DE-599)KXP1695562437 | ||
| 035 | |a (OCoLC)1341316030 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Weinberg, Benjamin A. |e VerfasserIn |0 (DE-588)1208743228 |0 (DE-627)1695569393 |4 aut | |
| 245 | 1 | 0 | |a NRG1-fusion positive gastrointestinal tumours |b afatinib as a novel potential treatment option |c B. Weinberg, D. Renouf, H. Lim, C. Heining, R. Schlenk, M. Jones, S. Liu, A. Cseh, F. Solca, J. Laskin |
| 246 | 3 | 0 | |a one |
| 264 | 1 | |c 2019 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Poster | ||
| 500 | |a Conference abstract P-291 | ||
| 500 | |a Gesehen am 21.04.2020 | ||
| 700 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 30(2019), Supplement 4, Seite iv80 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a NRG1-fusion positive gastrointestinal tumours afatinib as a novel potential treatment option |
| 773 | 1 | 8 | |g volume:30 |g year:2019 |g supplement:Supplement 4 |g pages:iv80 |g extent:1 |a NRG1-fusion positive gastrointestinal tumours afatinib as a novel potential treatment option |
| 856 | 4 | 0 | |u https://doi.org/10.1093/annonc/mdz155.290 |x Verlag |x Resolving-System |z lizenzpflichtig |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0923753419308075 |x Verlag |z lizenzpflichtig |
| 951 | |a AR | ||
| 992 | |a 20200421 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2019 | ||
| 998 | |g 129025380 |a Schlenk, Richard Friedrich |m 129025380:Schlenk, Richard Friedrich |d 910000 |d 910100 |e 910000PS129025380 |e 910100PS129025380 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 999 | |a KXP-PPN1695562437 |e 362858406X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1695562437","person":[{"given":"Benjamin A.","display":"Weinberg, Benjamin A.","family":"Weinberg","role":"aut"},{"role":"aut","family":"Schlenk","display":"Schlenk, Richard Friedrich","given":"Richard Friedrich"}],"note":["Poster","Conference abstract P-291","Gesehen am 21.04.2020"],"language":["eng"],"name":{"displayForm":["B. Weinberg, D. Renouf, H. Lim, C. Heining, R. Schlenk, M. Jones, S. Liu, A. Cseh, F. Solca, J. Laskin"]},"relHost":[{"id":{"issn":["1569-8041"],"eki":["320428796"],"zdb":["2003498-2"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Annals of oncology","title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology"}],"origin":[{"dateIssuedKey":"1990","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedDisp":"1990-"}],"recId":"320428796","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"NRG1-fusion positive gastrointestinal tumours afatinib as a novel potential treatment optionAnnals of oncology","corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"part":{"text":"30(2019), Supplement 4, Seite iv80","extent":"1","pages":"iv80","volume":"30","year":"2019"},"language":["eng"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1990 -"]}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"NRG1-fusion positive gastrointestinal tumours","subtitle":"afatinib as a novel potential treatment option","title_sort":"NRG1-fusion positive gastrointestinal tumours"}],"physDesc":[{"extent":"1 S."}],"id":{"doi":["10.1093/annonc/mdz155.290"],"eki":["1695562437"]}} | ||
| SRT | |a WEINBERGBENRG1FUSION2019 | ||